{"description":"Participants were able to report adverse events to the study team by email at any time. EHR and claims data were also analyzed for mortality.","eventGroups":[{"deathsNumAffected":0,"deathsNumAtRisk":495,"description":"Participants in this group will complete the baseline study activities, as described above. Additionally, participants will be instructed to create a Cue Health account and download the Cue Health App. Using the app and the 10 Cue Health COVID-19 molecular tests that are provided (or Cue Health Flu+COVID molecular tests if available and FDA authorized), the participant will perform tests after exposure or if symptoms arise. Participants can also use the test for close contacts who are exposed to COVID-19 and/or have symptoms. If COVID-19 infection occurs, participants will have access to telemedicine to discuss further with a healthcare professional. When clinically indicated, medication for the treatment of COVID-19 (and/or Influenza in case of Cue Health Flu+COVID test availability) will be prescribed and delivered to the participants' delivery address. Participants can also seek care through other healthcare providers or not seek care, at their discretion.\n\nAccess to Cue Health COVID-19 Remote testing and treatment for COVID-19: Participants will receive at home COVID-19 test for themselves and others in their household.","id":"EG000","otherNumAffected":0,"otherNumAtRisk":495,"seriousNumAffected":0,"seriousNumAtRisk":495,"title":"Intervention Arm"},{"deathsNumAffected":0,"deathsNumAtRisk":521,"description":"Participants in the control group will complete the baseline study activities, as described above. If symptoms arise or COVID-19 infection occurs, participants will test and seek care as they normally would.","id":"EG001","otherNumAffected":0,"otherNumAtRisk":521,"seriousNumAffected":0,"seriousNumAtRisk":521,"title":"Control Arm"}],"frequencyThreshold":"0","timeFrame":"Participants could report an adverse event at any time during their participation."}